GT Biopharma, Inc.GTBPNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank29
Year-over-Year Change
Earnings before interest, taxes, depreciation, and amortization
Percentile
P29
Within normal range
vs 2Y Ago
-5.7x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-34.32M | -160.8% |
| 2024 | $-13.16M | -320.1% |
| 2023 | $5.98M | +128.5% |
| 2022 | $-20.96M | +63.5% |
| 2021 | $-57.48M | -130.2% |
| 2020 | $-24.97M | +31.6% |
| 2019 | $-36.52M | +85.4% |
| 2018 | $-250.06M | -84.5% |
| 2017 | $-135.57M | -1346.4% |
| 2016 | $-9.37M | - |